Zynerba Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Zynerba Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2022.
  • Zynerba Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$11.1M, a 21.5% decline year-over-year.
  • Zynerba Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$38.8M, a 4.49% decline year-over-year.
  • Zynerba Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$35.3M, a 4.13% increase from 2021.
  • Zynerba Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$36.8M, a 29.4% increase from 2020.
  • Zynerba Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$52.1M, a 51.7% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$35.3M +$1.52M +4.13% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 -$36.8M +$15.3M +29.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$52.1M -$17.7M -51.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
2019 -$34.3M +$6.08M +15% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$40.4M -$7.57M -23.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-10
2017 -$32.8M -$9.62M -41.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
2016 -$23.2M -$10.7M -85.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-11
2015 -$12.5M -$6.86M -121% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$5.67M -$5.03M -793% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-27
2013 -$634K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.